Blood banking/immunohematology app Flashcards

1
Q

Red Blood Cell Membrane

A
  • Lipid bilayer
  • Carbohydrate and proteins inserted
  • > 300 antigens identified
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
2
Q

ABO system

A
  • Precursor H antigen (Bombay)
  • Two glycosylated antigens (A and B)
  • Four blood types (A, B, AB, and O)
  • Naturally-occurring antibodies
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
3
Q

Blood Typing

A
  • Forward – patient red blood cells
  • Reverse – patient serum
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
4
Q

Donors and Recipients

A

Red Blood Cells
* Type O – universal donor
* Type AB – universal recipient
Plasma
* Type AB – universal recipient
* Type O – universal donor

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
5
Q

Rh System

A
  • Antigens – D, c, C, e, E (no d antigen)
  • Rh-positive – D antigen present
  • Antibodies not naturally-occurring (transfusion or
    pregnancy)
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
6
Q

Minor Red Blood Cell Antigens

A
  • Kell (K/k)
  • Duffy (Fya/Fyb)
  • Kidd (Jka/Jkb)
  • MNS (M/N; S/s/U)
  • Lewis (Lea/Leb)
  • Lutheran (Lua/Lub)
  • P (P)
  • Others
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
7
Q

Blood Donation

A
  • Interval - every 56 days (whole blood)
  • Age - >16
  • Height/Weight – 5’4”/110 pounds
  • Feeling well
  • Deferral indications
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
8
Q

Deferral Indications for blood donation

A
  • Low hemoglobin
  • Donor medical history
  • Medications
  • Sexual history (HIV risk)
  • Travel history
  • Lifestyle factors
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
9
Q

Whole Blood Components

A
  • Packed red blood cells – 42 days, refrigerated
  • Platelets – 5 days, room temperature
  • Plasma – 1 year, frozen
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
10
Q

Apheresis

A
  • Selective removal of one component of blood (e.g.
    platelets, plasma, white blood cells, etc.)
  • Donation versus therapeutic applications
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
11
Q

Pre-transfusion Testing

A
  • Blood type of recipient
  • Blood type of donor
  • Antibody screen on recipient
  • Crossmatch
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
12
Q

Transfusion Reactions

A
  • Febrile versus non-febrile
  • Any febrile reaction is potentially serious
  • Immune versus non-immune
  • Hemolytic versus non-hemolytic
  • Immediate versus delayed
  • Mild versus severe
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
13
Q

Allergic Reaction

A
  • Allergen in transfused blood reacts with antibodies in
    recipient
  • No fever
  • Immediate reaction, non-hemolytic
  • Mild, usually local symptoms
  • Antihistamines
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
14
Q

Febrile Non-Hemolytic Transfusion Reaction

A
  • Cytokines in stored blood
  • Fever
  • Immediate, non-hemolytic
  • Usually mild
  • Acetaminophen
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
15
Q

Acute Hemolytic Transfusion Reaction

A
  • ABO incompatibility (clerical error)
  • Fever/chills, hypotension
  • Immediate, intravascular hemolysis
  • Severe (abdominal/back pain, respiratory distress,
    hemoglobinuria, disseminated intravascular
    coagulation, renal failure, circulatory collapse,
    “impending doom”, death)
  • Aggressive medical therapy
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
16
Q

Delayed Hemolytic Transfusion Reaction

A
  • Undetectable recipient antibodies
  • Fever
  • Delayed, hemolytic
  • Usually mild (jaundice, decrease in hemoglobin)
  • Supportive management
17
Q

Transfusion-Associated Circulatory Overload

A
  • Volume overload due to transfusion
  • No fever
  • Immediate
  • Moderate-severe (shortness of breath, cough, heart
    failure)
  • Diuretics, respiratory support
18
Q

Transfusion-Related Acute Lung Injury

A
  • Anti-leukocyte antibodies from donor (especially
    female donors), but normovolemic
  • Fever
  • Immediate, non-hemolytic
  • Severe (respiratory distress)
  • Supportive care, 5-25% mortality
19
Q

Transfusion-Associated GVH Disease

A
  • Donor lymphocytes (“graft”) proliferate and attack recipient
    cells (“host”)
  • Fever
  • Delayed, non-hemolytic
  • Severe (skin rash, hepatitis, diarrhea)
  • Difficult to manage, >90% mortality
  • Prevent by irradiating blood
20
Q

Post-Transfusion Purpura

A
  • Anti-platelet antibodies (PLA1) in recipient (mainly
    females)
  • Fever
  • Delayed, platelet destruction
  • May be severe (thrombocytopenia, bleeding)
  • Antigen-negative platelets, plasmapheresis
21
Q

Transfusion-Transmitted Infections

A
  • Overall incidence is very low
  • Bacterial infection – 1 in 5,000 to 1/30,000
  • HIV – 1 in 2,000,000
  • Hepatitis B – 1 in 300,000
  • Hepatitis C – 1 in 1,500,000
  • West Nile virus – 1 in 350,000
  • HTLV-1/2 – 1 in 3,000,000
22
Q

Selective IgA Deficiency

A
  • Decreased/absent IgA synthesis in recipient (anti-IgA
    antibodies react with IgA from donor)
  • May have fever
  • May be immediate
  • Most asymptomatic, but risk for anaphylaxis
  • IgA-negative donor, wash red blood cells to remove
    plasma
23
Q

Hemolytic Disease of the Newborn

A
  • Incompatibility between mother and baby (mother
    lacks an antigen expressed by baby)
  • Maternal antibodies cross placenta and cause
    hemolysis in baby
  • Most often ABO or Rh
  • ABO – usually mild, first pregnancy
  • Rh – may be more severe, previous exposure
  • Rh Immune globulin prophylaxis
24
Q

Transfusion Indications

A
  • Clinical evaluation rather than just numbers
  • Red blood cells – symptomatic anemia
  • 1 gm/dl hemoglobin rise per unit
  • Platelets – significant bleeding, thrombocytopenia
  • 30-60 x 103 platelet rise per transfusion
  • Plasma – significant bleeding, coagulation defect
  • 30% factor activity based on body weight and
    plasma volume
25
Pre-Transfusion Testing Times
* ABO/Rh typing – 10 minutes * ABO/Rh typing + antibody screen – 45 minutes * ABO/Rh typing + antibody screen + crossmatch – 60 minute * Crossmatch only (no antibodies) – 10 minutes
26
Emergency Situations
* Type O, Rh-negative red blood cells (especially young women) * Type AB plasma * Massive transfusion protocol - Prepared transfusion packs (red blood cells, plasma, platelets) available immediately - Tranexemic acid (anti-fibrinolytic) - Correction of metabolic derangements
27
What is the most appropriate next step to take? A. Wait for the results of the type and cross and order two units of compatible packed red blood cells B. Order 5 units of O-positive red blood cells and 5 units of AB-negative plasma C. Order 5 units of O-positive red blood cells and 5 units of O-positive plasma D. Order 5 units of A-positive red blood cells, because you recall the patient’s blood type is A-positive
28
If the patient requires additional red blood cell transfusions, which type of blood should be administered? A. Type A B. Type B C. Type AB D. Type O
29
What is the most likely cause for these findings? A. Underlying auto-immune disease B. Delayed hemolytic transfusion reaction C. Acute hemolytic transfusion reaction D. Transfusion-associated graft versus host disease E. Blood bank error
30
What is the most likely explanation for the presence of the antibody? A. She is Rh-positive and the baby is Rh-negative B. She is Rh-negative and received Rh immune globulin C. She is Rh-negative and has an underlying autoimmune disease D. She is Rh-positive and recently had a tattoo applied
31
What is the most likely cause for the observed febrile reaction? A. Allergic reaction B. Acute hemolytic transfusion reaction C. Delayed hemolytic transfusion reaction D. Febrile non-hemolytic transfusion reaction E. Bacterial contamination
32
What is the most appropriate next step? A. Examine the patient and when you find no problems, continue the transfusion because this is likely a repeat febrile reaction B. Pause the transfusion, administer acetaminophen, and then continue the transfusion if his temperature decreases C. Stop the transfusion and send a specimen to the blood bank for further work-up D. Call the transfusion center and tell them this is an expected reaction and that there is no need to further monitor his temperature
33
Case 3 (continued) Despite your recommendations, the transfusion is continued. Mr. Cooper now reports severe back pain, burning around the infusion site, dizziness, and he says “Doc, I feel really scared”. What is most likely cause of these findings? What is most likely cause of these findings? A. Acute hemolytic transfusion reaction B. Delayed hemolytic transfusion reaction C. Transfusion-related acute lung injury D. Septic reaction E. Anaphylaxis
34
What is the most likely cause of these results? A. Mr. Cooper got his wife’s blood, she is type A B. Mr. Cooper got his wife’s blood, she is type O C. The blood bank forgot to perform a crossmatch prior to transfusion D. The pre-transfusion sample was mixed up with that from another patient
35
What is the most likely cause of these findings and what is the most appropriate next step? A. Acute leukemia; leukapheresis B. Sickle cell crisis; red blood cell exchange transfusion C. Idiopathic thrombocytopenic purpura; plasmapheresis D. Thrombotic thrombocytopenic purpura; plasma exchange E. Autoimmune hemolytic anemia; plasmapheresis
36
Case 5 A 72-year-old man is admitted with GI bleeding. The patient was on warfarin, so fresh frozen plasma is ordered to reverse the effect of the warfarin. Approximately 15 minutes into the transfusion, the patient develops a rash, shortness of breath, periorbital swelling, and quickly progressed to profound hypotension and respiratory distress. What is the most likely cause for these findings? What is the most likely cause for these findings? A. Transfusion-associated circulatory overload B. Transfusion-related acute lung injury C. Septic reaction D. Anaphylaxis E. Acute hemolytic transfusion reaction Which of the following is the most likely cause of this reaction? A. Anti-IgA antibodies in the recipient B. Donor lymphocytes in the plasma C. Anti-HLA antibodies in the plasma D. Bacteria in the plasma E. Anti-ABO antibodies in the patient